Sun protection factor persistence during a day with physical activity and bathing

Photodermatology Photoimmunology and Photomedicine

Volumn 24, Issue 6, 2008, Pages 296-300

  Bodekær, Mette ^a   Faurschou, Annesofie ^a   Philipsen, Peter Alshede ^a   Wulf, Hans Christian ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Durability; Sun protection factor; Sunscreen

Indexed keywords

4 METHOXYCINNAMIC ACID 2 ETHYLHEXYL ESTER; AVOBENZONE; CLINIDERM; OCTOCRYLENE; SALICYLIC ACID OCTYL ESTER; SUNSCREEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BATH; CALCULATION; CONTROLLED STUDY; ERYTHEMA; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RADIATION EXPOSURE; SKIN PROTECTION; SUN EXPOSURE; ULTRAVIOLET B RADIATION; VOLUNTEER;

ADULT; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MALE; MOTOR ACTIVITY; SUNBURN; SUNLIGHT; SUNSCREENING AGENTS; SWIMMING;

EID: 56349123772     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2008.00379.x     Document Type: Article

References (28)

1. Melnikova VO, Ananthaswamy HN. Cellular and molecular events leading to the development of skin cancer. Mutat Res 2005; 571: 91-106.
2. Lautenschlager S, Wulf HC, Pittelkow MR. Photoprotection. Lancet 2007; 370: 528-537.
3. World Health Organisation. Sun protection message for tourists. Available at: http://www.who.int/uv/publications/en/tourists. Accessed 8 January 2007.
4. Wulf HC, Poulsen T, Brodthagen H, Hou-Jensen K. Sunscreens for delay of ultraviolet induction of skin tumors. J Am Acad Dermatol 1982; 7: 194-202.
5. Kligman LH, Akin FJ, Kligman AM. Sunscreens prevent ultraviolet photocarcinogenesis. J Am Acad Dermatol 1980; 3: 30-35.
6. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993; 329: 1147-1151.
7. Naylor MF, Boyd A, Smith DW, Cameron GS, Hubbard D, Neldner KH. High SPF sunscreens in the suppression of actinic neoplasia. Arch Dermatol 1995; 131: 170-175.
8. Darlington S, William G, Neale R, Frost C, Green A. A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses. Arch Dermatol 2003; 139: 451-455.
9. Diffey BL. When should sunscreen be reapplied? J Am Acad Dermatol 2001; 45: 882-885.
10. Agin PP, Levine DJ. Sunscreens retain their efficacy on human skin for up to 8h after application. J Photochem Photobiol B 1992; 15: 371-374.
11. Eaglstein WH, Taplin D, Mertz P, Smiles KA. An all-day test for the evaluation of a topical sunscreen. J Am Acad Dermatol 1980; 2: 513-520.
12. Odio MR, Veres DA, Goodman JJ, et al. Comparative efficacy of sunscreen reapplication regimens in children exposed to ambient sunlight. Photodermatol Photoimmunol Photomed 1994; 10: 118-125.
13. U.S. Food and Drug Administration, Department of Health and Human Services FDA. Sunscreen drug products for over-the-counter human use. Available at: http://www.fda.gov/cder/otcmonographs/Sunscreen/ sunscreen(352). Accessed 6 December 2006.
14. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988; 124: 869-871.
15. Hansen AB, Bech-Thomsen N, Wulf HC. Erythema after irradiation with ultraviolet B from Philips TL12 and TL01 tubes. Photodermatol Photoimmunol Photomed 1994; 10: 22-25.
16. Wulf HC, Lock-Andersen J. The Scandinavian Photodermatology Research Group. Standard erythema dose. Skin Res Technol 1996; 4: 192.
17. Lock-Andersen J, Wulf HC. Threshold level for measurement of UV sensitivity: Reproducibility of phototest. Photodermatol Photoimmunol Photomed 1996; 12: 154-161.
18. Janjua NR, Mogensen B, Andersson AM, et al. Systemic absorption of the sunscreens benzophenone-3, octyl-methoxycinnamate, and 3-(4-methyl-benzylidene) camphor after whole-body topical application and reproductive hormone levels in humans. J Invest Dermatol 2004; 123: 57-61.
19. Gamer AO, Leibold E, van Ravenzwaay B. The in vitro absorption of microfine zincoxide and titanium dioxide through porcine skin. Toxicol In Vitro 2006; 20: 301-307.
20. Lademann J, Weigmann H, Rickmeyer C, Barthelmes H, Schaefer H, Mueller G, Sterry W. Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol Appl Skin Physiol 1999; 12: 247-256.
21. Thieden E, Philipsen PA, Sandby-Moeller J, Wulf HC. Sunscreen use related to UV exposure, age, sex, and occupation based on personal dosimeter readings and sun-exposure behavior diaries. Arch Dermatol 2005; 141: 967-973.
22. Wulf HC, Stender IM, Lock-Andersen J. Sunscreens used at the beach do not protect against erythema: A new definition of SPF is proposed. Photodermatol Photoimmunol Photomed 1997; 13: 129-132.
23. Bech-Thomsen N, Wulf HC. Sunbathers' application of sunscreen is probably inadequate to obtain the sun protection factor assigned to the preparation. Photodermatol Photoimmunol Photomed 1992/1993; 9: 242-244.
24. Neale R, Williams G, Green A. Application patterns among participants randomized to daily sunscreen use in a skin cancer prevention trial. Arch Dermatol 2002; 138: 1319-1325.
25. Autier P, Boniol M, Severi G, Doré J-F. Quantity of sunscreen used by European students. Br J Dermatol 2001; 144: 288-291.
26. Faurschou A, Wulf HC. The relation between sun protection factor and amount of suncreen applied in vivo. Br J Dermatol 2007; 156: 716-719.
27. Bimczok R, Gers-Barlag H, Mundt C, et al. Influence of applied quantity of sunscreen products on the sun protection factor-a multicenter study organized by the DGK Task Force Sun Protection. Skin Pharmacol Physiol 2007; 20: 57-64.
28. Pruim B, Green A. Photobiological aspects of sunscreen re-application. Australas J Dermatol 1999; 40: 14-18.